Clinical Trials Suggest: Improved OS With Abiraterone and Enzalutamide+SoC, Apalutamide Significantly Reduced the Risk of Death by 33% in mCSPC Receiving ADT

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Clinical Trials Suggest: Improved OS With Abiraterone and Enzalutamide+SoC, Apalutamide Significantly Reduced the Risk of Death by 33% in mCSPC Receiving ADT

By UNC Lineberger Comprehensive Cancer Center FEATURING Young Whang

325 views

March 26, 2020

The UNC Cancer Network (UNCCN) partners with many communities across North Carolina to enhance cancer ...
read more ↘ care, and to provide support and education for all North Carolinians. Services include twenty-four free oncology lectures, delivered online, annually. All lectures include FREE CNE, ASRT, and ACPE credit. Research to Practice lectures also include FREE CME credit. Details may be found at https://www.unccn.org/
UNCCN is a part of the UNC Lineberger Comprehensive Cancer Center. Please contact us at unccn@unc.edu for more information.
↖ read less

0 Comments